Showing results (11-20 of 49) with videos related to
Sort By:
Pageof 5
Acta Haematologica|June 11, 2024
Effect of Digital Health Coaching on Self-Efficacy and Patient-Reported Outcomes in Individuals with Acute Myeloid and Chronic Lymphocytic Leukemia: A Pilot Randomized Controlled TrialJennifer Marvin-Peek, Valerie Shelton, Kelly Brassil, et al.Haematologica|June 26, 2025
Lower-intensity chemo-immunotherapy with cladribine, low-dose cytarabine, venetoclax and blinatumomab produces high response rates in patients with BCR::ABL1-negative B-cell / myeloid mixed phenotype acute leukemiaRoberta S Azevedo, Wei-Ying Jen, Danielle Hammond, et al.Haematologica|May 14, 2026
Outcomes of patients diagnosed with myelodysplastic syndrome or acute myeloid leukemia following solid organ transplantationCharan Thej Reddy Vegivinti, Guillermo Montalban-Bravo, Kelly Chien, et al.Cancer Medicine|March 18, 2024
Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasmsKelly S Chien, Faustine Ong, Kunhwa Kim, et al.Rheumatology (Oxford, England)|November 25, 2025
Establishing a consensus definition of VEXAS flare for clinical researchLachelle D Weeks, Danielle Hammond, Sinisa Savic, et al.British Journal of Haematology|November 10, 2023
Phase 1/2 study of CPX-351 for patients with Int-2 or high risk International Prognostic Scoring System myelodysplastic syndromes and chronic myelomonocytic leukaemia after failure to hypomethylating agentsGuillermo Montalban-Bravo, Elias Jabbour, Gautam Borthakur, et al.Leukemia Research|May 14, 2024
Phase 1 study of azacitidine in combination with quizartinib in patients with FLT3 or CBL mutated MDS and MDS/MPNGuillermo Montalban-Bravo, Elias Jabbour, Kelly Chien, et al.Journal of Clinical Medicine|February 27, 2026
PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS SyndromeDavid B Beck, Maël Heiblig, Sinisa Savic, et al.Hemasphere|October 24, 2025
A Phase 2 study of CPX-351 in combination with venetoclax in patients with newly diagnosed high-risk acute myeloid leukemiaWei-Ying Jen, Jennifer Croden, Emmanuel Almanza-Huante, et al.Leukemia & Lymphoma|March 31, 2025
Mutation dynamics from diagnosis to relapse in acute myeloid leukemia with chromosomal 7 deletionsEitan Kugler, Enes Dasdemir, Alex Bataller, et al.Pageof 5